MYC.md
... ...
@@ -15,9 +15,9 @@ MYC is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) a
15 15
|:------:|:----:|--------------------------------------|
16 16
|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@dunsCharacterizationDLBCLPMBL2021]|
17 17
|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@jalladesExomeSequencingIdentifies2017]|
18
-|![BL](images/icons/BL_tier1.png) |1-a | aSHM target and high-confidence BL gene [@johnstonCmycHypermutationBurkitt1992]|
19
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene [@pasqualucciHypermutationMultipleProtooncogenes2001]|
20
-|![FL](images/icons/FL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous |
18
+|![BL](images/icons/BL_tier1.png) |1 | aSHM target and high-confidence BL gene [@johnstonCmycHypermutationBurkitt1992]|
19
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 | aSHM target and high-confidence DLBCL gene [@pasqualucciHypermutationMultipleProtooncogenes2001]|
20
+|![FL](images/icons/FL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous |
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23